Canon Eyes Medical, Chip Tools in $25 Billion Expansion

Canon has unveiled a new five-year strategic plan, signaling a significant investment of ¥3 trillion to bolster its current operations. Concurrently, the company is prepared to allocate as much as an additional ¥2 trillion toward potential acquisitions, with a keen focus on expanding into high-growth sectors like medical devices and semiconductor manufacturing equipment.

Shareholder returns are projected to exceed ¥1 trillion over the next five years. While the dividend payout ratio has been adjusted to approximately 40%, down from a previous benchmark of 50%, Canon remains committed to a flexible approach regarding share buybacks, aiming to balance profitability with investor rewards.

Amidst market shifts, particularly in the camera industry and the capital-intensive semiconductor equipment arena, the company faces leadership questions. CEO Fujio Mitarai, aged 90, addressed speculation about his tenure, suggesting his desire to continue leading through the new five-year plan, though a definitive succession announcement remains pending.